Biomarkers of chemotaxis and inflammation in cerebrospinal fluid and serum in individuals with HIV-1 subtype C versus B Sergio M. de AlmeidaIndianara RottaThe HNRC Group OriginalPaper 11 July 2016 Pages: 715 - 724
Bovine herpesviruses induce different cell death forms in neuronal and glial-derived tumor cell cultures Tereza C. CardosoAna Carolina G. RosaEduardo F. Flores OriginalPaper 16 June 2016 Pages: 725 - 735
Host cell virus entry mechanisms enhance anti-JCV-antibody switch in natalizumab-treated multiple sclerosis patients Anat AchironGadi MironMichael Gurevich OriginalPaper 11 May 2016 Pages: 736 - 746
HIV-1 Tat causes cognitive deficits and selective loss of parvalbumin, somatostatin, and neuronal nitric oxide synthase expressing hippocampal CA1 interneuron subpopulations William D. MarksJason J. ParisKurt F. Hauser OriginalPaper 13 May 2016 Pages: 747 - 762
A study on viral CNS inflammation beyond herpes encephalitis Berit JordanSabrina KöslingMalte Kornhuber OriginalPaper 12 May 2016 Pages: 763 - 773
Exosome-associated release, uptake, and neurotoxicity of HIV-1 Tat protein Pejman RahimianJohnny J. He OriginalPaper 12 May 2016 Pages: 774 - 788
Suicide risk and prevalence of major depressive disorder (MDD) among individuals infected with HIV-1 subtype C versus B in Southern Brazil Sergio Monteiro de AlmeidaFrancisco Jaime BarbosaHNRC Group OriginalPaper 18 July 2016 Pages: 789 - 798
Adenovirus-mediated shRNA interference against HSV-1 replication in vitro Bo SongXinjing LiuYuming Xu OriginalPaper 26 August 2016 Pages: 799 - 807
Utility of a brief computerized battery to assess HIV-associated neurocognitive impairment in a resource-limited setting Nirupama YechoorSheri L. ToweChristina S. Meade OriginalPaper 31 May 2016 Pages: 808 - 815
Preliminary study of a novel cognitive assessment device for the evaluation of HIV-associated neurocognitive impairment Albert M. AndersonJeffrey L. LennoxDavid W. Loring OriginalPaper 31 May 2016 Pages: 816 - 822
The complement system, neuronal injury, and cognitive function in horizontally-acquired HIV-infected youth Jennifer L. McGuireAlexander J. GillCNS HIV Antiretroviral Therapy Effects Research (CHARTER) Group OriginalPaper Open access 06 June 2016 Pages: 823 - 830
The flavivirus dengue induces hypertrophy of white matter astrocytes Kim M. LeeKevin B. ChiuAndrew G. MacLean OriginalPaper 06 June 2016 Pages: 831 - 839
Elevated stress is associated with prefrontal cortex dysfunction during a verbal memory task in women with HIV Leah H. RubinMinjie WuPauline M. Maki OriginalPaper 19 April 2016 Pages: 840 - 851
Discordant CSF/plasma HIV-1 RNA in patients with unexplained low-level viraemia Sam NightingaleAnna Maria GerettiSaye Khoo OriginalPaper Open access 18 May 2016 Pages: 852 - 860
Acute myelitis as presenting symptom of HIV-HTLV-1 co-infection A. CuccaL. StragapedeP. Manganotti Short Communication 31 May 2016 Pages: 861 - 865
β-Adrenergic receptor gene expression in HIV-associated neurocognitive impairment and encephalitis: implications for MOR-1K subcellular localization Seth M. DeverMyosotys RodriguezNazira El-Hage Short Communication 11 July 2016 Pages: 866 - 870
Natalizumab-treated patients at high risk for PML persistently excrete JC polyomavirus Milton H. WernerDeRen Huang Short Communication Open access 19 May 2016 Pages: 871 - 875
Normonatremic osmotic demyelination in the setting of acquired immune deficiency syndrome and malnutrition: case report and literature review James E. SieglerAmber R. WangJoshua D. Vanderwerf Case Report 12 July 2016 Pages: 876 - 879
Statistical analysis of PML incidences of natalizumab-treated patients from 2009 to 2016: outcomes after introduction of the Stratify JCV® DxSelect™ antibody assay Denise CampagnoloQunming DongHarold Koendgen Letter to the Editor Open access 11 October 2016 Pages: 880 - 881